• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 研究进展一年:卡塔尔新冠疫情爆发的基因组特征分析。

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar.

机构信息

Biomedical Research Center, Qatar University, Doha, Qatar.

Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.

出版信息

Front Cell Infect Microbiol. 2021 Nov 17;11:768883. doi: 10.3389/fcimb.2021.768883. eCollection 2021.

DOI:10.3389/fcimb.2021.768883
PMID:34869069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8637114/
Abstract

Qatar, a country with a strong health system and a diverse population consisting mainly of expatriate residents, has experienced two large waves of COVID-19 outbreak. In this study, we report on 2634 SARS-CoV-2 whole-genome sequences from infected patients in Qatar between March-2020 and March-2021, representing 1.5% of all positive cases in this period. Despite the restrictions on international travel, the viruses sampled from the populace of Qatar mirrored nearly the entire global population's genomic diversity with nine predominant viral lineages that were sustained by local transmission chains and the emergence of mutations that are likely to have originated in Qatar. We reported an increased number of mutations and deletions in B.1.1.7 and B.1.351 lineages in a short period. These findings raise the imperative need to continue the ongoing genomic surveillance that has been an integral part of the national response to monitor the SARS-CoV-2 profile and re-emergence in Qatar.

摘要

卡塔尔拥有强大的卫生系统和以侨民为主的多元化人口,经历了两次大规模的 COVID-19 疫情爆发。在这项研究中,我们报告了 2020 年 3 月至 2021 年 3 月期间卡塔尔感染患者的 2634 个 SARS-CoV-2 全基因组序列,占该期间所有阳性病例的 1.5%。尽管对国际旅行实行了限制,但从卡塔尔民众中采样的病毒反映了几乎全球所有人的基因组多样性,存在九个主要的病毒谱系,这些谱系是由当地传播链维持的,并且出现了可能起源于卡塔尔的突变。我们报告说,在短时间内,B.1.1.7 和 B.1.351 谱系中的突变和缺失数量增加。这些发现凸显了继续进行全基因组监测的必要性,这是国家应对 COVID-19 的重要组成部分,以监测卡塔尔的 SARS-CoV-2 特征和再次出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/55b364438536/fcimb-11-768883-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/0d7f4cd34358/fcimb-11-768883-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/98c831b22725/fcimb-11-768883-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/5b79d83bc9eb/fcimb-11-768883-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/cdb7721742b4/fcimb-11-768883-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/55b364438536/fcimb-11-768883-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/0d7f4cd34358/fcimb-11-768883-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/98c831b22725/fcimb-11-768883-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/5b79d83bc9eb/fcimb-11-768883-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/cdb7721742b4/fcimb-11-768883-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f09/8637114/55b364438536/fcimb-11-768883-g005.jpg

相似文献

1
One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar.SARS-CoV-2 研究进展一年:卡塔尔新冠疫情爆发的基因组特征分析。
Front Cell Infect Microbiol. 2021 Nov 17;11:768883. doi: 10.3389/fcimb.2021.768883. eCollection 2021.
2
COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar.利用基于污水的流行病学在卡塔尔监测 COVID-19(SARS-CoV-2)疫情。
Sci Total Environ. 2021 Jun 20;774:145608. doi: 10.1016/j.scitotenv.2021.145608. Epub 2021 Feb 9.
3
SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.新冠病毒变异株 B.6 是马来西亚早期大流行传播的主要贡献者。
PLoS Negl Trop Dis. 2020 Nov 30;14(11):e0008744. doi: 10.1371/journal.pntd.0008744. eCollection 2020 Nov.
4
Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar.通过高通量多重PCR进行实时SARS-CoV-2基因分型揭示卡塔尔关注变异株的流行病学情况。
Int J Infect Dis. 2021 Nov;112:52-54. doi: 10.1016/j.ijid.2021.09.006. Epub 2021 Sep 12.
5
Emergence and Spread of SARS-CoV-2 Lineages B.1.1.7 and P.1 in Italy.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系B.1.1.7和P.1在意大利的出现与传播。
Viruses. 2021 Apr 29;13(5):794. doi: 10.3390/v13050794.
6
SARS-CoV-2 infection rates in air passengers arriving in Qatar.抵达卡塔尔的航空乘客中的新冠病毒感染率。
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab163.
7
Genomic Elucidation of a COVID-19 Resurgence and Local Transmission of SARS-CoV-2 in Guangzhou, China.中国广州 COVID-19 疫情反弹和 SARS-CoV-2 本地传播的基因组解析
J Clin Microbiol. 2021 Jul 19;59(8):e0007921. doi: 10.1128/JCM.00079-21.
8
Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers.从阿联酋旅行者中分离和鉴定 SARS-CoV-2 Beta 变异株。
J Infect Public Health. 2022 Feb;15(2):182-186. doi: 10.1016/j.jiph.2021.12.011. Epub 2021 Dec 24.
9
Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada.加拿大 SARS-CoV-2 前两波的基因组流行病学。
Elife. 2022 Aug 2;11:e73896. doi: 10.7554/eLife.73896.
10
Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia.俄罗斯 SARS-CoV-2 疫情早期的基因组流行病学研究。
Nat Commun. 2021 Jan 28;12(1):649. doi: 10.1038/s41467-020-20880-z.

引用本文的文献

1
Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.ChAdOx1 nCoV-19(Vaxzevria)初级系列疫苗对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)贝塔和德尔塔变异株的有效性:一项全国性研究。
BMC Infect Dis. 2025 Aug 17;25(1):1028. doi: 10.1186/s12879-025-11410-7.
2
Immune histories and natural infection protection during the omicron era.奥密克戎时代的免疫史与自然感染防护
Commun Med (Lond). 2025 Jul 1;5(1):262. doi: 10.1038/s43856-025-00974-9.
3
Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar.

本文引用的文献

1
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals.卡塔尔城市人口中新冠病毒血清流行率:对112941人样本的抗体检测分析
iScience. 2021 Jun 25;24(6):102646. doi: 10.1016/j.isci.2021.102646. Epub 2021 May 24.
2
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.BNT162b2新冠疫苗对B.1.1.7和B.1.351变异株的有效性
N Engl J Med. 2021 Jul 8;385(2):187-189. doi: 10.1056/NEJMc2104974. Epub 2021 May 5.
3
Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa.
评估新冠病毒疫苗有效性研究中的健康接种者效应:卡塔尔的一项全国队列研究。
Elife. 2025 Jun 9;14:e103690. doi: 10.7554/eLife.103690.
4
Comprehensive analysis of human coronavirus antibody responses in ICU and non-ICU COVID-19 patients reveals IgG3 against SARS-CoV-2 spike protein as a key biomarker of disease severity.对ICU和非ICU新冠肺炎患者的人类冠状病毒抗体反应进行的综合分析显示,针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的IgG3是疾病严重程度的关键生物标志物。
J Med Microbiol. 2025 May;74(5). doi: 10.1099/jmm.0.002012.
5
Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron.奥密克戎毒株出现前后对新冠病毒再感染的差异保护作用。
Nature. 2025 Mar;639(8056):1024-1031. doi: 10.1038/s41586-024-08511-9. Epub 2025 Feb 5.
6
Mutational Patterns Observed in SARS-CoV-2 Genomes Sampled From Successive Epochs Delimited by Major Public Health Events in Ontario, Canada: Genomic Surveillance Study.在加拿大安大略省由重大公共卫生事件界定的连续时期内采集的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组中观察到的突变模式:基因组监测研究
JMIR Bioinform Biotechnol. 2022 Dec 22;3(1):e42243. doi: 10.2196/42243.
7
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.SARS-CoV-2 BA.2.86 高效进入肺部细胞并逃避中和抗体。
Cell. 2024 Feb 1;187(3):596-608.e17. doi: 10.1016/j.cell.2023.12.025. Epub 2024 Jan 8.
8
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design.估算既往感染在预防再次感染方面提供的保护:应用病例对照研究设计。
Am J Epidemiol. 2024 Jun 3;193(6):883-897. doi: 10.1093/aje/kwad239.
9
Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12-17 Years against COVID-19 Infection in Qatar.辉瑞-生物科技mRNA疫苗对卡塔尔12至17岁儿童和青少年预防新冠病毒感染的效果
Vaccines (Basel). 2023 Sep 25;11(10):1522. doi: 10.3390/vaccines11101522.
10
History of primary-series and booster vaccination and protection against Omicron reinfection.初级系列和加强针接种史与奥密克戎再感染的保护作用。
Sci Adv. 2023 Oct 6;9(40):eadh0761. doi: 10.1126/sciadv.adh0761. Epub 2023 Oct 4.
南非开普敦多次引入 SARS-CoV-2。
Viruses. 2021 Mar 22;13(3):526. doi: 10.3390/v13030526.
4
Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational study.香港新冠疫情夏冬季爆发的系统发育基因组学分析:一项观察性研究。
Lancet Reg Health West Pac. 2021 May;10:100130. doi: 10.1016/j.lanwpc.2021.100130. Epub 2021 Mar 23.
5
Near-Complete Genome Sequence of a SARS-CoV-2 VOC 202012/01 Strain in Peru.秘鲁一株严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株202012/01的近完整基因组序列
Microbiol Resour Announc. 2021 Mar 25;10(12):e00069-21. doi: 10.1128/MRA.00069-21.
6
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic.描述卡塔尔严重阶段 SARS-CoV-2 疫情特征。
Sci Rep. 2021 Mar 18;11(1):6233. doi: 10.1038/s41598-021-85428-7.
7
SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview.SARS-CoV-2 谱系及其在全球传播的亚谱系:动态概述。
Chemotherapy. 2021;66(1-2):3-7. doi: 10.1159/000515340. Epub 2021 Mar 18.
8
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.SARS-CoV-2 变体 B.1.351 和 B.1.1.7 的抗体抗性。
Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8.
9
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.在英格兰,估计 SARS-CoV-2 谱系 B.1.1.7 的传染性和影响。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
10
Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.来自巴西里约热内卢的新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系的基因组特征分析
J Virol. 2021 Apr 26;95(10). doi: 10.1128/JVI.00119-21. Epub 2021 Mar 1.